Pharmaceutical Monitoring of a Case of Pulmonary Hemorrhage with Coagulation Dysfunction in a 680 g Extremely Low Birth Weight Infant at 25+1 Weeks Gestation
Journal of Biology and Health Science · 2026 · 03 (02)
DOI: 10.56147/jbhs.3.2.137 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biology and Health Science, 2026. Verfasst von Li Longkuan und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Objective
To conduct pharmaceutical monitoring for a case of Pulmonary Hemorrhage (PH) accompanied by coagulation dysfunction in a 680 g Extremely Low Birth Weight (ELBW) infant at 25+1 weeks of gestation and to provide a reference for the clinical treatment of PH in ELBW infants.
Methods
The patient's bleeding treatment regimen was optimized. Interventions included the use of tranexamic acid for antifibrinolytic hemostasis, transfusion of fresh frozen plasma (9 times) and cryoprecipitate (4 times), vitamin K₁ supplementation to improve coagulation function, subcutaneous injection of heparin calcium for anticoagulation (2 times) and administration of human fibrinogen to elevate fibrinogen levels (2 times).
Results
The patient's bleeding was successfully controlled. Following two administrations of human fibrinogen, the infant's coagulation function and Platelet count (PLT) were essentially restored to normal.
Conclusion
When coagulation dysfunction occurs in ELBW infants, vigilance for the onset of pulmonary hemorrhage is crucial. The use of fibrinogen-containing interventions can improve coagulation function and mitigate risk factors for pulmonary hemorrhage in these patients.
Zitieren
APA
Longkuan, L., Wei, Z., Jing, J., & Guifa, Y. (2026). Pharmaceutical Monitoring of a Case of Pulmonary Hemorrhage with Coagulation Dysfunction in a 680 g Extremely Low Birth Weight Infant at 25+1 Weeks Gestation. Journal of Biology and Health Science, 03(02). https://doi.org/10.56147/jbhs.3.2.137
Vancouver
Longkuan L, Wei Z, Jing J, Guifa Y. Pharmaceutical Monitoring of a Case of Pulmonary Hemorrhage with Coagulation Dysfunction in a 680 g Extremely Low Birth Weight Infant at 25+1 Weeks Gestation. Journal of Biology and Health Science. 2026;03(02). doi:10.56147/jbhs.3.2.137
BibTeX
@article{Longkuan2026,
author = {Longkuan, Li and Wei, Zhang and Jing, Jiang and Guifa, Yu},
title = {Pharmaceutical Monitoring of a Case of Pulmonary Hemorrhage with Coagulation Dysfunction in a 680 g Extremely Low Birth Weight Infant at 25+1 Weeks Gestation},
journal = {Journal of Biology and Health Science},
year = {2026},
volume = {03},
number = {02},
doi = {10.56147/jbhs.3.2.137}
}
EUVIMED